{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Deferoxamine", "query": { "intervention": "Deferoxamine" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 33, "total_pages": 4, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Deferoxamine&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-03T13:50:01.317Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00061763", "title": "Study of Deferasirox in Iron Overload From Beta-thalassemia Unable to be Treated With Deferoxamine or Chronic Anemias", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Beta-thalassemia", "Myelodysplastic Syndromes", "Fanconi Syndrome", "Anemia, Diamond-Blackfan", "Anemia, Aplastic" ], "interventions": [ { "name": "Deferasirox", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 175, "start_date": "2003-05", "completion_date": null, "has_results": false, "last_update_posted_date": "2017-08-22", "last_synced_at": "2026-09-03T13:50:01.317Z", "location_count": 6, "location_summary": "Oakland, California • Stanford, California • Arlington Heights, Illinois + 3 more", "locations": [ { "city": "Oakland", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Arlington Heights", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00061763" }, { "nct_id": "NCT02443545", "title": "Long-term Safety and Efficacy of Ferriprox® in Iron Overloaded Patients With Sickle Cell Disease or Other Anemias", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Iron Overload", "Sickle Cell Disease", "Other Anemias" ], "interventions": [ { "name": "Deferiprone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ApoPharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "3 Years", "maximum_age": null, "sex": "ALL", "summary": "3 Years and older" }, "enrollment_count": 134, "start_date": "2015-05-21", "completion_date": "2019-08-21", "has_results": true, "last_update_posted_date": "2024-01-10", "last_synced_at": "2026-09-03T13:50:01.317Z", "location_count": 5, "location_summary": "Oakland, California • Ann Arbor, Michigan • Detroit, Michigan + 2 more", "locations": [ { "city": "Oakland", "state": "California" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Detroit", "state": "Michigan" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Charleston", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT02443545" }, { "nct_id": "NCT00901199", "title": "Combined Chelation Therapy in Patients With Transfusion Dependent Thalassemia and Iron Overload", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Thalassemia", "Iron Overload" ], "interventions": [ { "name": "Combo Chelation with Deferasirox (Exjade) and Deferoxamine (DFO)", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Elliott Vichinsky", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "8 Years", "maximum_age": null, "sex": "ALL", "summary": "8 Years and older" }, "enrollment_count": 22, "start_date": "2007-09", "completion_date": "2012-10", "has_results": true, "last_update_posted_date": "2021-08-12", "last_synced_at": "2026-09-03T13:50:01.317Z", "location_count": 1, "location_summary": "Oakland, California", "locations": [ { "city": "Oakland", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00901199" }, { "nct_id": "NCT07162363", "title": "Synergistic Minimally Invasive Surgery and Deferoxamine in ICH", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Intracerebral Hemorrhage", "ICH - Intracerebral Hemorrhage" ], "interventions": [ { "name": "Minimally Invasive surgery (MIS)", "type": "PROCEDURE" }, { "name": "Deferoxamine", "type": "DRUG" }, { "name": "Standard Medical Care (SMD)", "type": "OTHER" } ], "intervention_types": [ "PROCEDURE", "DRUG", "OTHER" ], "sponsor": "University of Illinois at Chicago", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 240, "start_date": "2026-03-01", "completion_date": "2028-12-30", "has_results": false, "last_update_posted_date": "2025-10-10", "last_synced_at": "2026-09-03T13:50:01.317Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT07162363" }, { "nct_id": "NCT00000623", "title": "Thalassemia (Cooley's Anemia) Clinical Research Network (TCRN)", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Anemia, Cooley's", "Beta-Thalassemia", "Hematologic Diseases", "Thalassemia", "Osteoporosis", "Iron Overload", "Hypertension, Pulmonary" ], "interventions": [ { "name": "Deferoxamine", "type": "DRUG" }, { "name": "Deferiprone", "type": "DRUG" }, { "name": "Arginine", "type": "DRUG" }, { "name": "Sildenafil", "type": "DRUG" }, { "name": "Decitabine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Carelon Research", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "1 Year", "maximum_age": "75 Years", "sex": "ALL", "summary": "1 Year to 75 Years" }, "enrollment_count": 1000, "start_date": "2000-07", "completion_date": "2006-07", "has_results": false, "last_update_posted_date": "2014-03-04", "last_synced_at": "2026-09-03T13:50:01.317Z", "location_count": 4, "location_summary": "Oakland, California • Boston, Massachusetts • New York, New York + 1 more", "locations": [ { "city": "Oakland", "state": "California" }, { "city": "Boston", "state": "Massachusetts" }, { "city": "New York", "state": "New York" }, { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00000623" }, { "nct_id": "NCT02216513", "title": "Deferoxamine to Prevent Delayed Cerebral Ischemia After Subarachnoid Hemorrhage", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "EARLY_PHASE1" ], "conditions": [ "Subarachnoid Hemorrhage" ], "interventions": [ { "name": "desferrioxamine (DFO)", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2, "start_date": "2014-09", "completion_date": "2015-07", "has_results": false, "last_update_posted_date": "2015-07-21", "last_synced_at": "2026-09-03T13:50:01.317Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT02216513" }, { "nct_id": "NCT02041299", "title": "Efficacy and Safety of Ferriprox® in Patients With Sickle Cell Disease or Other Anemias", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Iron Overload", "Sickle Cell Disease", "Other Anemias" ], "interventions": [ { "name": "Deferiprone", "type": "DRUG" }, { "name": "Deferoxamine", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "ApoPharma", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "2 Years", "maximum_age": null, "sex": "ALL", "summary": "2 Years and older" }, "enrollment_count": 230, "start_date": "2014-04-17", "completion_date": "2019-06-18", "has_results": true, "last_update_posted_date": "2021-08-10", "last_synced_at": "2026-09-03T13:50:01.317Z", "location_count": 8, "location_summary": "Oakland, California • Chicago, Illinois • New Orleans, Louisiana + 4 more", "locations": [ { "city": "Oakland", "state": "California" }, { "city": "Chicago", "state": "Illinois" }, { "city": "New Orleans", "state": "Louisiana" }, { "city": "Ann Arbor", "state": "Michigan" }, { "city": "Detroit", "state": "Michigan" } ], "official_url": "https://clinicaltrials.gov/study/NCT02041299" }, { "nct_id": "NCT00738413", "title": "Iron Balance Study of Deferasirox, Deferoxamine and the Combination of Both", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Thalassemia" ], "interventions": [ { "name": "Deferoxamine", "type": "DRUG" }, { "name": "Deferasirox", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Weill Medical College of Cornell University", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "50 Years", "sex": "ALL", "summary": "18 Years to 50 Years" }, "enrollment_count": 6, "start_date": "2008-08", "completion_date": "2009-12", "has_results": false, "last_update_posted_date": "2010-11-05", "last_synced_at": "2026-09-03T13:50:01.317Z", "location_count": 1, "location_summary": "New York, New York", "locations": [ { "city": "New York", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT00738413" }, { "nct_id": "NCT06863233", "title": "A Study of CD8+ T Cell Imaging During Treatment in People With Non-Small Cell Lung Cancer", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Lung Cancer", "Non Small Cell Lung Cancer", "Metastatic Non Small Cell Lung Cancer" ], "interventions": [ { "name": "Zirconium Zr 89 crefmirlimab berdoxam", "type": "DRUG" }, { "name": "PET/CT Scan", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DRUG", "DIAGNOSTIC_TEST" ], "sponsor": "Memorial Sloan Kettering Cancer Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 4, "start_date": "2025-03-03", "completion_date": "2026-08-24", "has_results": false, "last_update_posted_date": "2026-08-26", "last_synced_at": "2026-09-03T13:50:01.317Z", "location_count": 7, "location_summary": "Basking Ridge, New Jersey • Middletown, New Jersey • Montvale, New Jersey + 4 more", "locations": [ { "city": "Basking Ridge", "state": "New Jersey" }, { "city": "Middletown", "state": "New Jersey" }, { "city": "Montvale", "state": "New Jersey" }, { "city": "Commack", "state": "New York" }, { "city": "Harrison", "state": "New York" } ], "official_url": "https://clinicaltrials.gov/study/NCT06863233" }, { "nct_id": "NCT00293098", "title": "Compassionate Use of Deferiprone for Patients With Thalassemia and Iron-Induced Heart Disease", "overall_status": "APPROVED_FOR_MARKETING", "study_type": "EXPANDED_ACCESS", "phases": [], "conditions": [ "Iron Overload" ], "interventions": [ { "name": "deferiprone", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Children's Hospital of Philadelphia", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": null, "start_date": "2006-03", "completion_date": null, "has_results": false, "last_update_posted_date": "2012-02-09", "last_synced_at": "2026-09-03T13:50:01.317Z", "location_count": 1, "location_summary": "Philadelphia, Pennsylvania", "locations": [ { "city": "Philadelphia", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00293098" } ] }